Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to $8.1 million.

  • GeoVax Labs' Cash from Financing Activities fell 5028.79% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year decrease of 1052.13%. This contributed to the annual value of $23.8 million for FY2024, which is 48463.64% up from last year.
  • Latest data reveals that GeoVax Labs reported Cash from Financing Activities of $8.1 million as of Q3 2025, which was down 5028.79% from $209.0 recorded in Q2 2025.
  • In the past 5 years, GeoVax Labs' Cash from Financing Activities registered a high of $18.5 million during Q2 2022, and its lowest value of -$25801.0 during Q2 2021.
  • Over the past 5 years, GeoVax Labs' median Cash from Financing Activities value was $7.6 million (recorded in 2022), while the average stood at $7.1 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 10244.39% in 2021, then soared by 7179688.38% in 2022.
  • Quarter analysis of 5 years shows GeoVax Labs' Cash from Financing Activities stood at $230000.0 in 2021, then skyrocketed by 3215.45% to $7.6 million in 2022, then crashed by 46.73% to $4.1 million in 2023, then increased by 14.91% to $4.7 million in 2024, then skyrocketed by 74.11% to $8.1 million in 2025.
  • Its Cash from Financing Activities was $8.1 million in Q3 2025, compared to $209.0 in Q2 2025 and $7.9 million in Q1 2025.